GP2015: An Etanercept Biosimilar

BioDrugs - United Kingdom
doi 10.1007/s40259-017-0246-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Observational Study of Inflammatory Arthritis Treatment by Etanercept Originator Switched to an Etanercept Biosimilar

Reumatologia
RheumatologyAllergyImmunology
2019English

Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review

Rheumatology and Therapy
2019English

Evaluation of the Cost Saving Potential of Introducing an Etanercept Biosimilar (Benepali®) for the Treatment of All Licensed Adult Etanercept Indications in the UK

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

SAT0199 Switch From Innovator Etanercept to Biosimilar Etanercept in Inflammatory Rheumatic Diseases: The Experience of Cochin University Hospital Paris-France.

2018English

Switch From Reference Etanercept to SDZ ETN, an Etanercept Biosimilar, Does Not Impact Efficacy, Safety, and Immunogenicity of Etanercept in Patients With Moderate-To-Severe Rheumatoid Arthritis: 48-Week Results From the Phase III, Randomized, Double-Blind EQUIRA Study

Arthritis Research & Therapy
2019English

Response To: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

Journal of Immunology Research
MedicineAllergyImmunology
2018English

PF-06438179/GP1111: An Infliximab Biosimilar

BioDrugs
MedicineBiotechnologyPharmacology
2018English

Pms70 - Biosimilar and Originator Etanercept: Influence of Local Policy Measures and Practices on Market Dynamics Between Swedish Counties

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar

BioDrugs
MedicineBiotechnologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy